Journal of Family and Reproductive Health (Sep 2010)

Development of New Therapeutic Strategies in Gynecological Cancers in Iran by Utilizing Xenograft Model of Ovarian Adenocarcinoma

  • Zohreh Mazaheri,
  • Samad Muhammadnejad,
  • Ahad Muhammadnejad,
  • Moein Zargarzadeh,
  • Maryam Haghighi,
  • Mohammad Ali Oghabian,
  • Farrokh Tirgari,
  • Saeid Amanpour

Journal volume & issue
Vol. 4, no. 3

Abstract

Read online

Objective: To evaluate the potentiality of OVCAR–3 cell line of ovarian adenocarcinoma as a xenograft model for ovarian adenocarcinoma in nude mice. Materials and methods: The cell line isolated from advanced human ovarian adenocarcinoma, were inoculated to eight nude mice and two months later. Established tumors were transferred to pathology laboratory to be prepared by H&E staining and immunohistochemical staining with CA125 antibody. Results: Study of H&E slides showed advanced adenocarcinoma. The CA125 Tumor marker was also positive in tumoral tissue. Conclusion: Established tumors showed excellently the characteristics of ovarian adenocarcinoma. This model can be used to evaluate new treatment strategies.

Keywords